OBJECTIVE: To evaluate whether serum lipoprotein subclasses and related metabolites quantified by nuclear magnetic resonance (NMR) are associated with longitudinal tensor-based morphometry (TBM) atrophy in mild cognitive impairment (MCI). METHODS: Secondary analysis of ADNI-GO and ADNI-2 participants with a baseline diagnosis of MCI, baseline serum Nightingale NMR metabolomics, and at least 2 quality-controlled T1-weighted MRI examinations processed with the Mayo TBM-SyN pipeline. The TBM-SyN summary score was the mean annualized log-Jacobian volume change across 31 Alzheimer disease (AD) -vulnerable regions, derived from baseline-to-follow-up symmetric registration. Linear mixed-effects models adjusted for age and included subject-level random intercepts. Associations with the Clinical Dementia Rating (CDR) and the Alzheimer Disease Assessment Scale (ADAS) were tested. RESULTS: The analytic cohort included 93 participants (mean age: 65. 23 y, SD: 6. 47; 51 male, 54. 8%). Eight biomarkers were significantly associated with TBM-SyN atrophy: medium HDL free cholesterol percentage (MHDLFCPCT; β=-0. 0020, P=0. 0016), apolipoprotein B (P=0. 005), apolipoprotein A1 (P=0. 017), extra-large HDL particle concentration (XLHDLP; P=0. 029), medium HDL particle concentration (P=0. 028), medium HDL cholesterol (P=0. 025), medium HDL cholesterol esters (P=0. 031), and glycerol (P=0. 038). XLHDLP alone was associated with the CDR score (P=0. 03). CONCLUSIONS: Specific HDL-related lipoprotein subclasses, apolipoproteins, and glycerol are associated with TBM-derived structural atrophy in MCI, supporting peripheral lipid metabolism as a candidate scalable correlate of early neurodegeneration.
Khosravi et al. (Wed,) studied this question.